Previous Close | 0.1650 |
Open | 0.1800 |
Bid | 3.5000 x 500 |
Ask | 4.7500 x 500 |
Day's Range | 0.1800 - 0.1800 |
52 Week Range | 0.1400 - 0.3000 |
Volume | |
Avg. Volume | 33,237 |
Market Cap | 9.392M |
Beta (5Y Monthly) | 0.09 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0220 |
Earnings Date | Aug 11, 2022 - Aug 15, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for HEWA
CINCINNATI, May 12, 2022--HealthWarehouse.com, Inc. (OTC:HEWA) announced today net sales for the first quarter of 2022 totaled $4,314,980, a 13% increase over the same period in 2021, resulting from strong growth in partner services revenue and an increase in direct-to-consumer sales. The Company reported a loss from operations of $213,988 for the quarter while generating positive cash flow of $64,047, as reflected by Adjusted EBITDA (the Company’s non-GAAP internal measure).
CINCINNATI, March 17, 2022--HealthWarehouse.com, Inc. said its net sales for 2021 were $16,143,906, with higher prescription sales driven by partner services revenue.
CINCINNATI, November 15, 2021--HealthWarehouse.com, Inc. (OTCQB: HEWA) announced net sales for the third quarter of 2021 were $4,212,127, a 5% increase from the same quarter in 2020, with prescription sales increasing 13%. The Company reported a loss from operations of $181,031 for its quarter ended September 30, 2021, but positive cash flow, as reflected by its internal non-GAAP measure of Adjusted EBITDA as defined below, which was $89,797 in the third quarter.